SciELO - Scientific Electronic Library Online

 
vol.15 número3Défice de alfa -1 antitripsina. A experiência do Hospital de Pulido Valente com a terapêutica de reposiçãoEmpiema torácico - Revisão baseada em três casos clínicos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Portuguesa de Pneumologia

versão impressa ISSN 0873-2159

Rev Port Pneumol v.15 n.3 Lisboa maio 2009

 

Actualização em doença pulmonar tromboembólica

 

Márcia Man 1

António Bugalho 2

 

 

Resumo

A doença pulmonar tromboembólica, parte integrante do tromboembolismo venoso, constitui um importante problema de saúde, dado que acarreta um risco significativo de mortalidade e morbilidade, com elevado custo social e económico. O diagnóstico e terapêutica atempados, bem como uma profilaxia apropriada, são factores determinantes no prognóstico. Esta entidade clínica continua a suscitar particular atenção, nomeadamente no que respeita à investigação dos factores de risco, desenvolvimento de algoritmos de probabilidade clínica, avaliação dos exames complementares de diagnóstico, definição de novas abordagens terapêuticas e recomendações para tromboprofilaxia. No presente trabalho procura -se rever o conhecimento científico actual relativo ao tromboembolismo pulmonar, focando as vertentes anteriormente mencionadas.

Palavras-chave: Tromboembolismo pulmonar, tromboembolismo venoso, diagnóstico, tratamento, profilaxia, anticoagulação.

 

 

Update in pulmonary thromboembolic disease 

Abstract

Pulmonary embolism is part of venous thromboembolism, an important health problem which leads to significant mortality and morbidity with high economic and social burden. A prompt diagnosis and treatment as well as an appropriate prophylaxis are determinant factors in prognosis. This disease continues to demand particular attention namely in the investigation of risk factors, clinical probability algorithms development, diagnostic work -up evaluation, characterization of new therapeutic strategies and thromboprophylaxis recommendations. The present review looks into the current scientific knowledge regarding pulmonary embolism.

Key -words: Pulmonary embolism, venous thromboembolism, diagnosis, treatment, prophylaxis, anticoagulation.

 

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

 

Bibliografia

1. Prevention and treatment of venous thromboembolism: International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006; 25: 101 -161.

2. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23 suppl 1): I4 -18.         [ Links ]

3. Jaffer AK. An overview of venous thromboembolism: impact, risks, and issues in prophylaxis. Cleveland Clinic Journal of Medicine 2008; 75: S3 -S6.

4. Silverstein MD, Heit JA, Mohr DN, Lohse CM, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25 -year population -based study. Arch Intern Med 1998; 158: 585 -593.

5. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism. American College of Chest Physicians Evidence -based Clinical Practical Guidelines (8th Edition). Chest 2008; 133:381S -453S.

6. Dexter L, Folch Pi W. Venous thrombosis: an account of the first documented case. J Am Med Ass 1974; 228:195 -196.

7. Mannucci PM. Venous thrombosis: the history of knowledge. Pathophysiol Haemost Thromb 2002; 32: 209 -212.

8. Ferrier J. An affectation of the lymphatic vessels hither to misunderstood. Medical Histories and Reflections 1810; (III).

9. De Bakey ME. Collective review: a critical evaluation of the problems of thromboembolism. International Abstracts of Sugery 1954; 98: 1 -27.

10. Bauer G. A roentgenological and clinical study of the sequels of thrombosis. Acta Chirur Scandin 1942; 86: 106 -112.

11. Dickson BC. Venous thrombosis: on the history of Virchow’s triad. UTMJ 2004; 81: 166 -171.

12. Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23 suppl 1): I9 -I16.

13. Anderson Jr FA, Wheeler HB. Physician practices in the management of venous thromboembolism: a community -wide survey. J Vasc Surg 1992; 16: 707-714.

14. Collins R, Scrimgeour A, Yussuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1998; 318: 1162 -1173.

15. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601 -1606.

16. Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 2004; 164: 1653 -1661.

17. Stein PD, Beemath A, Meyers FA, Kayali F, Skaf E, Olson RE. Pulmonary embolism: a cause of death in patients who died with cancer. Am J Med 2006; 119: 163 -165.

18. Pandroni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.

19. Jacques R, Paul Man SF, Don D Sin. Prevalence of pulmonary embolism in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta -analysis, Chest 2008; 23. [Epub ahead of print] (Acedido em Outubro de 2008).

20. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta -analysis. Ciculation 2008; 117: 93 -102.

21. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. A prospective study of risk factors for pulmonar embolism in women. JAMA 1997; 277: 642 -645.

22. Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F, Leydon GM. A comparison of the risks of venous thromboembolic disease in association with different combien oral contraceptives. Br J Clin Pharmacol 2000; 49: 580 -590.

23. Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk thrombosis and acts synergically with oral contraceptive use. Am J Hematol 2008; 83: 97-102.

24. Danilenko -Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary tion based, case control study. Am J Obstet Gynecol 2001; 184: 104 -110.

25. Kukovich JL. Hormones and pregnancy: thrombolic risks for women. Br J Haematol 2004; 126: 443 -454.

26. Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E. Thrombotic variables and risk of idiopatic venous thromboembolism in women aged 45 -64 years. Relationships to hormone replacement therapy. Thromb Haemost 2000; 83: 530 -535.

27. Lip Gy, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 1999; 33: 1424 -1426.

28. Warlow C, Ogston D, Douglas AS. Venous thrombosis following strokes. Lancet 1972; 1: 1305 -1306.

29. National Space and Aeronautics Administration. Flight -related deep vein thrombosis –economy class syndrome. http://ohp.nasa.gov/topics/alerts/dvt.html. (Acedido em Outubro de 2008).

30. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism – results of the Spanish Multicentric Study on Thrombophilia (EMET -Study). Thromb Heamost 1997; 77: 444 -451.

31. Crowther MA, Kelton JG. Congenital thrombofilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003; 138: 128 -134.

32. Eichinger S, Weltermann A, Minar E, Stain M, Schonauer V, Schneider B, Kyrle PA. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92 -96.

33. Weinman EE, Salzman EW. Deep vein thrombosis. N Engl J Med 1994; 331: 1630 -1641.

34. Goldhaber S. Pulmonary embolism. Lancet 2004; 363: 1295 -1305.

35. Belenkie L, Dani R, Smith ER, Tyberg JV. Ventricular interaction during experimental acute pulmonary embolism. Circulation 1998; 78: 761 -768.

36. Minichielli T, Fogarty PF. Diagnosis and management of venous thormboembolism. Med Clin N Am 2008: 443 -465.

37. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000; 201: 1301 -1336.

38. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 2005; 112: e28 -32.

39. Stein PD, Beemath A, Matta F, Weg JG, Yusen RD, Hales CA, Hull RD, Leeper KV Jr, Sostman HD, Tapson VF, Buckley JD, Gottschalk A, Goodman LR, Wakefied TW, Woodard PK. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007; 120: 871 -879.

40. Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007; 5 (Supl 1): 41 -50.

41. West J, Goodacre S, Sampson F. The value of clinical features in the diagnosis of acute pulmonary embolism: systematic review and meta -analysis. QJM 2007; 100: 763 -769.

42. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK. D –dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140: 589 -602.

43. Kline JA, Runyon MS, Webb WB, Jones AE, Mitchell AM. Prospective study of the diagnostic accuracy of the simplified d -dimer assay for pulmonary embolism in emergency department patients. Chest 2006; 129: 1417 -1423.

44. Kearon C, Ginsberg JS, Douketis J, Turpie AG, Bates SM, Lee AY, Crowther MA, Weitz JI, Brill-Edwards P, Wells P, Anderson DR, Kovacs MJ, Linkins LA, Julian JA, Bonilla LR, Gent M. Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Group. An evaluation of d -dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006; 144: 812 -821.

45. Kiely DG, Kennedy NS, Pirzada O, Batchelor SA, Struthers AD, Lipworth BJ. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Resp Med 2005; 99: 1286 -1291.

46. Klok FA, Mos IC, Huisman MV. Brain -type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta -analysis. Am J Respir Crit Care Med 2008; 178: 425 -430.

47. Giannitsis E, Muller -Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus HA. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211 -217.

48. Pruszczyk P, Bochowicz A, Torbicki A, Szulc M, Kurzyna M, Fijałkowska A, Kuch -Wocial A. Cardiac troponin T monitoring identifies high risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123: 1947 -1952.

49. Rodger MA, Carrier M, Jones GN, Rasuli P, Raymond F, Djunaedi H, Wells PS. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Resp Crit Care Med 2000; 162: 2105 -2108.

50. Task Force on Pulmonary Embolism. European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301 -1336.

51. Gibson NS, Sohne M, Buller HR. Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism. Curr Opin Pulm med 2005; 11: 380 -384.

52. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002; 136: 691 -700.

53. Zierler B. Ultrassonography and diagnosis of venous thromboembolism. Circulation 2004; 109: I9 -14.

54. The PIOPED Investigators. Value of the ventilation/perfusion scanning scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753 -2759.

55. Hayashino Y, Goto M, Noguchi Y, Fukui T. Ventilation -perfusion scanning and helical CT in suspected pulmonary embolism: meta -analysis of diagnostic performance. Radiology 2005; 234: 740 -748.

56. Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation 2004; 109: 2160 -2167.

57. Perrier A, Nendaz MR, Sarasin FP, Howarth N, Bournameaux H. Cost -effectiveness analysis of diagnostic strategies for suspected thromboembolism including helical computed tomography. Am Resp Crit Care Med 2003; 167 (1): 39 -44.

58. Pistolesi M, Miniati M. Imaging techniques in treatment algorithms of pulmonary embolism. Eur Resp J 2002; 19 (Suppl 35): 28S -39S.

59. Hofmann LV, Lee DS, Gupta A, Arepally A, Sood S, Girgis R, Eng J. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10 year single center experience. AJR Am J Roentgenol 2004; 183: 779 -786.

60. Hudson ER, Smith TP, McDermott VG, Newman GE, Suhocki PV, Payne CS, Stackhouse DJ. Pulmonary angiography performed with iopamidol: complications in 1434 patients. Radiology 1996; 198: 61 -65.

61. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple -cause mortality data. Arch Intern Med 2003; 163: 1711 -1717.

62. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23 suppl 1): I22 -30.

63. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, Sitbon O, Simonneau G. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637 -648.

64. ten Wolde M, Sohne M, Quak E, Mac Gillavry MR, Buller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004; 164: 1685 -1689.

65. Pieralli F, Olivotto I, Vanni S, Conti A, Camaiti A, Targioni G, Grifoni S, Berni G. Usefulness of bedside testing brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 2006; 97: 1386 -1390.

66. Torbicki A, Galie N, Covezzoli A, Rossi E, De Rosa M, Goldhaber SZ. ICOPER Study Group. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 2003; 41: 2245 -2251.

67. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta -analysis. Circulation 2007; 116: 427 -433.

68. Kearon C, Kahn S, Agnelli G, Goldhaber S, Raskob E, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease. American College of Chest Physicians Evidence -based Clinical Practical Guidelines (8th Edition). Chest 2008; 133: 454S -545S.

69. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular -weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta -analysis of randomized, controlled trials. Ann Intern Med 2004;140: 175 -183.

70. Morris TA, Castrejon S, Devendra G, Gamst AC. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low -molecular -weight heparin or unfractionated heparin: a metaanalysis. Chest 2007;132: 1108 -1110.

71. Turpie AG, Gallus AS, Hoek JA. A synthetic pentassacaride for the prevention of deep vein thrombosis. N Eng J Med 2001; 344: 619 -625.

72. http://www.fda.gov/medwatch/SAFETY/2004/may_PI/Arixtra_PI.pdf (Acedido Outubro 2008)

73. Wysowsky DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse event resulting in regulatory action. Arch Intern Med 2007; 167: 1414 -1419.

74. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. American College of Chest Physicians Evidence -based Clinical Practical Guidelines (8th Edition). Chest 2008; 133: 160S -198S.

75. Goldhaber SZ. Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction. Arch Inter Med 2005; 165: 2197 -2199.

76. Thabut G, Thabut D, Myers RP, Bernard –Chabert B, Marrash -Chahla R, Mal H, Fournier M. Thrombolityc therapy of pulmonary embolism: a meta -analysis. J Am Coll Cardiol 2002; 40: 1600 -1607.

77. Dong B, Jirong Y, Liu G, Wang Q, Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2006; CD004437.

78. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol 2006; 134: 590 -595.

79. Eight year follow -up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112: 416 -422.

80. Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest 2006;129: 192 -197.

81. Naina HV, Quevedo FJ. Acute pulmonar embolism. N Engl J Med 2008:358 (10): 1037 -1052.

82. Brueil AL, Umland EM. Outpatient management of anticoagulation therapy. Am Fam Physician 2007; 75: 1031-1042.

83. Dunn AS, Turpie AG. Perioperative management of patients receiving antoicoagulants: a systematic review. Arch Intern Med 2003; 163: 901 -908.

84. Jafri SM. Periprocedual thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3 -15.

85. Douketis JD, Johnson JA, Turpie AG. Low molecular weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedual anticoagulation regimen. Arch Intern Med 2004; 164: 1319 -1326.

86. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE Study): a multinational cross –sectional study. Lancet 2008; 371. 387 -394.

87. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Eng J Med 1999; 341: 793 -800.

88. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874 -879.

89. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ 2006; 332: 325 -329.

90. Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Turpie AG, Wildgoose P, Yusen RD. Extended -duration venous thromboembolism prophylaxis in acutely ill medical patients with recent reduced mobility: the EXCLAIM study. J Thromb Haemost 2007; 5 (Supl 2): OS001.

 

 

1 Interna do Internato Complementar de Pneumologia

2 Assistente Hospitalar de Pneumologia

Departamento de Pneumologia, Centro Hospitalar Lisboa Norte, Hospital de Pulido Valente, Portugal

 

Recebido para publicação/received for publication: 08.11.03

Aceite para publicação/accepted for publication: 08.12.19